Your browser doesn't support javascript.
loading
Implementing the 4R and 9H regimens for TB preventive treatment in Indonesia.
Apriani, L; Koesoemadinata, R C; Bastos, M L; Wulandari, D A; Santoso, P; Alisjahbana, B; Rutherford, M E; Hill, P C; Benedetti, A; Menzies, D; Ruslami, R.
Afiliación
  • Apriani L; TB Working Group, Infectious Disease Research Center, Universitas Padjadjaran, Bandung, Indonesia, Department of Public Health, Faculty of Medicine, Universitas Padjadjaran, Bandung, Indonesia.
  • Koesoemadinata RC; TB Working Group, Infectious Disease Research Center, Universitas Padjadjaran, Bandung, Indonesia.
  • Bastos ML; Outcomes Research and Evaluation, Research Institute of the McGill University Health Centre, Montreal, QC, Canada.
  • Wulandari DA; Department of Child Health, Universitas Padjadjaran/Dr Hasan Sadikin General Hospital, Bandung, Indonesia.
  • Santoso P; TB Working Group, Infectious Disease Research Center, Universitas Padjadjaran, Bandung, Indonesia, Department of Internal Medicine, Faculty of Medicine, Universitas Padjadjaran/Dr Hasan Sadikin General Hospital, Bandung, Indonesia.
  • Alisjahbana B; TB Working Group, Infectious Disease Research Center, Universitas Padjadjaran, Bandung, Indonesia, Department of Internal Medicine, Faculty of Medicine, Universitas Padjadjaran/Dr Hasan Sadikin General Hospital, Bandung, Indonesia.
  • Rutherford ME; Centre for International Health, Department of Preventive and Social Medicine, University of Otago, Otago, New Zealand.
  • Hill PC; Centre for International Health, Department of Preventive and Social Medicine, University of Otago, Otago, New Zealand.
  • Benedetti A; Outcomes Research and Evaluation, Research Institute of the McGill University Health Centre, Montreal, QC, Canada, Departments of Epidemiology, Biostatistics and Occupational Health, and Medicine, McGill University, Montreal, QC, Canada.
  • Menzies D; Outcomes Research and Evaluation, Research Institute of the McGill University Health Centre, Montreal, QC, Canada, Departments of Epidemiology, Biostatistics and Occupational Health, and Medicine, McGill University, Montreal, QC, Canada.
  • Ruslami R; TB Working Group, Infectious Disease Research Center, Universitas Padjadjaran, Bandung, Indonesia, Department of Biomedical Sciences, Faculty of Medicine, Universitas Padjadjaran, Bandung, Indonesia.
Int J Tuberc Lung Dis ; 26(2): 103-110, 2022 02 01.
Article en En | MEDLINE | ID: mdl-35086621
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Tuberculosis Latente / Antituberculosos Tipo de estudio: Clinical_trials / Incidence_studies / Prognostic_studies Límite: Adult / Child / Humans País/Región como asunto: Asia Idioma: En Revista: Int J Tuberc Lung Dis Año: 2022 Tipo del documento: Article País de afiliación: Indonesia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Tuberculosis Latente / Antituberculosos Tipo de estudio: Clinical_trials / Incidence_studies / Prognostic_studies Límite: Adult / Child / Humans País/Región como asunto: Asia Idioma: En Revista: Int J Tuberc Lung Dis Año: 2022 Tipo del documento: Article País de afiliación: Indonesia